Review



primary human dermal lymphatic endothelial cells lecs  (PromoCell)


Bioz Verified Symbol PromoCell is a verified supplier
Bioz Manufacturer Symbol PromoCell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    PromoCell primary human dermal lymphatic endothelial cells lecs
    Primary Human Dermal Lymphatic Endothelial Cells Lecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 97/100, based on 269 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human dermal lymphatic endothelial cells lecs/product/PromoCell
    Average 97 stars, based on 269 article reviews
    primary human dermal lymphatic endothelial cells lecs - by Bioz Stars, 2026-02
    97/100 stars

    Images



    Similar Products

    97
    PromoCell primary human dermal lymphatic endothelial cells lecs
    Primary Human Dermal Lymphatic Endothelial Cells Lecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human dermal lymphatic endothelial cells lecs/product/PromoCell
    Average 97 stars, based on 1 article reviews
    primary human dermal lymphatic endothelial cells lecs - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    PromoCell hdlecs
    Hdlecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hdlecs/product/PromoCell
    Average 97 stars, based on 1 article reviews
    hdlecs - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    PromoCell primary human dermal lymphatic endothelial cells hdlecs
    Primary Human Dermal Lymphatic Endothelial Cells Hdlecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human dermal lymphatic endothelial cells hdlecs/product/PromoCell
    Average 97 stars, based on 1 article reviews
    primary human dermal lymphatic endothelial cells hdlecs - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    PromoCell human dermal lymphatic endothelial cells
    Human Dermal Lymphatic Endothelial Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human dermal lymphatic endothelial cells/product/PromoCell
    Average 97 stars, based on 1 article reviews
    human dermal lymphatic endothelial cells - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    PromoCell juvenile single donor male human dermal lecs
    Mixed junctional state in capillary LV. (A and B) Whole mounts prepared from the upper 200 µm of the human dermis showing PDPN + LVs and the distribution of the junctional protein VE-cadherin (VE-cad). Representative images from n = 8 donors are shown. (A) Blind-ended lymphatic capillaries with oak leaf–shaped <t>LECs</t> (depicted by an asterisk) or more elongated LECs (depicted by an arrow) were observed in human dermis. (B) Images of LVs with oak leaf–shaped LECs joined by button junctions (depicted by an asterisk) or LVs with more elongated, zipper-like LECs (depicted by an arrow), as well as BVs joined with zipper junctions. Scale bars: 20 µm. (C) Whole mounts of human dermis (upper 200 µm) showing the presence of intracellular CCL21 in afferent LVs stained with anti-VE-cadherin or anti-PDPN antibodies. Representative images from n = 3 donors are shown. Scale bars: 20 µm. (D) GO term analysis of genes enriched in the cap2 LEC subset compared with all other LEC subsets. Selected terms for enriched GO biological and cellular processes are shown along with the −log 10 of the adjusted P value (list of marker genes for the enrichment analysis in ). The vertical line represents the adjusted P value set at an FDR of 0.05. (E) Volcano plot of DEGs between cap1 and cap2 LEC subsets. The horizontal line shows the log 2 fold change (FC) threshold set at 0.75. Vertical lines show the significance threshold for adjusted P values set at an FDR of 0.05. (F) Individual UMAP plots showing the expression of specific cap2 LEC genes, i.e., WWTR1 , ITGA9 , PTK2 , YAP1 , ITGAV , FBN1 . (G and H) Whole mounts prepared from the upper 200 µm of the human dermis showing PDPN + LVs expressing (G) the focal adhesion kinase (FAK), and (H) FAK and the chemokine CCL21. Representative images from n = 3 donors are shown (G and H). Scale bars: 20 µm. For the FAK images, a thin stack at the level of the LV was made to visualize FAK expression specifically in LECs. (I) Human <t>dermal</t> <t>LECs</t> were subjected to mechanical stretch (10% strain every 30 s for 18 h) with a bioreactor. Representative immunofluorescence images of control (static) human dermal LECs and human dermal LECs subjected to stretching are shown. VE-cadherin was used to visualize the cell boundary and subsequent elongation. Scale bar: 100 µm. (J) Aspect ratio of control LECs or stretched LECs was quantified and is represented as a box plot. Statistics were computed with the nonparametric Mann–Whitney test. Pooled data were derived from n = 3 independent replicates with 695 cells analyzed in total. ***P < 0.001. (K) RNA of control or stretched human dermal LECs was extracted, and RT-qPCR was performed. The fold change expression levels of CCL21 and LYVE1 between stretched and control samples are depicted. A fold change below one shows reduced gene expression under stretched conditions. Two independent experiments from n = 3 human dermal LEC donors, with four pooled technical replicates for each. Statistics were computed with paired Student’s t test. **P <0.01. (L) Violin plots showing differential expression of CCL21 and LYVE1 in the cap1 and cap2 clusters. Statistics: the P adjusted value is shown. ***P <0.001. FDR, false discovery rate.
    Juvenile Single Donor Male Human Dermal Lecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/juvenile single donor male human dermal lecs/product/PromoCell
    Average 97 stars, based on 1 article reviews
    juvenile single donor male human dermal lecs - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    PromoCell juvenile human dermal lymphatic endothelial cells
    Lymphatic <t>endothelial</t> cells (LEC) were supplemented with various concentrations of glutamine (Gln; top pathway) or had their glutamine transport inhibited with V-9302 (bottom pathway). After initial treatments, cells were then incubated in normoxic (∼21% O 2 ) or hypoxic (>3% O 2 ) conditions. Image created in BioRender.
    Juvenile Human Dermal Lymphatic Endothelial Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/juvenile human dermal lymphatic endothelial cells/product/PromoCell
    Average 97 stars, based on 1 article reviews
    juvenile human dermal lymphatic endothelial cells - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    PromoCell hdlec
    Lymphatic <t>endothelial</t> cells (LEC) were supplemented with various concentrations of glutamine (Gln; top pathway) or had their glutamine transport inhibited with V-9302 (bottom pathway). After initial treatments, cells were then incubated in normoxic (∼21% O 2 ) or hypoxic (>3% O 2 ) conditions. Image created in BioRender.
    Hdlec, supplied by PromoCell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hdlec/product/PromoCell
    Average 97 stars, based on 1 article reviews
    hdlec - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    PromoCell ispinesib treatment human dermal lecs hdlecs
    Lymphatic <t>endothelial</t> cells (LEC) were supplemented with various concentrations of glutamine (Gln; top pathway) or had their glutamine transport inhibited with V-9302 (bottom pathway). After initial treatments, cells were then incubated in normoxic (∼21% O 2 ) or hypoxic (>3% O 2 ) conditions. Image created in BioRender.
    Ispinesib Treatment Human Dermal Lecs Hdlecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ispinesib treatment human dermal lecs hdlecs/product/PromoCell
    Average 97 stars, based on 1 article reviews
    ispinesib treatment human dermal lecs hdlecs - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    Image Search Results


    Mixed junctional state in capillary LV. (A and B) Whole mounts prepared from the upper 200 µm of the human dermis showing PDPN + LVs and the distribution of the junctional protein VE-cadherin (VE-cad). Representative images from n = 8 donors are shown. (A) Blind-ended lymphatic capillaries with oak leaf–shaped LECs (depicted by an asterisk) or more elongated LECs (depicted by an arrow) were observed in human dermis. (B) Images of LVs with oak leaf–shaped LECs joined by button junctions (depicted by an asterisk) or LVs with more elongated, zipper-like LECs (depicted by an arrow), as well as BVs joined with zipper junctions. Scale bars: 20 µm. (C) Whole mounts of human dermis (upper 200 µm) showing the presence of intracellular CCL21 in afferent LVs stained with anti-VE-cadherin or anti-PDPN antibodies. Representative images from n = 3 donors are shown. Scale bars: 20 µm. (D) GO term analysis of genes enriched in the cap2 LEC subset compared with all other LEC subsets. Selected terms for enriched GO biological and cellular processes are shown along with the −log 10 of the adjusted P value (list of marker genes for the enrichment analysis in ). The vertical line represents the adjusted P value set at an FDR of 0.05. (E) Volcano plot of DEGs between cap1 and cap2 LEC subsets. The horizontal line shows the log 2 fold change (FC) threshold set at 0.75. Vertical lines show the significance threshold for adjusted P values set at an FDR of 0.05. (F) Individual UMAP plots showing the expression of specific cap2 LEC genes, i.e., WWTR1 , ITGA9 , PTK2 , YAP1 , ITGAV , FBN1 . (G and H) Whole mounts prepared from the upper 200 µm of the human dermis showing PDPN + LVs expressing (G) the focal adhesion kinase (FAK), and (H) FAK and the chemokine CCL21. Representative images from n = 3 donors are shown (G and H). Scale bars: 20 µm. For the FAK images, a thin stack at the level of the LV was made to visualize FAK expression specifically in LECs. (I) Human dermal LECs were subjected to mechanical stretch (10% strain every 30 s for 18 h) with a bioreactor. Representative immunofluorescence images of control (static) human dermal LECs and human dermal LECs subjected to stretching are shown. VE-cadherin was used to visualize the cell boundary and subsequent elongation. Scale bar: 100 µm. (J) Aspect ratio of control LECs or stretched LECs was quantified and is represented as a box plot. Statistics were computed with the nonparametric Mann–Whitney test. Pooled data were derived from n = 3 independent replicates with 695 cells analyzed in total. ***P < 0.001. (K) RNA of control or stretched human dermal LECs was extracted, and RT-qPCR was performed. The fold change expression levels of CCL21 and LYVE1 between stretched and control samples are depicted. A fold change below one shows reduced gene expression under stretched conditions. Two independent experiments from n = 3 human dermal LEC donors, with four pooled technical replicates for each. Statistics were computed with paired Student’s t test. **P <0.01. (L) Violin plots showing differential expression of CCL21 and LYVE1 in the cap1 and cap2 clusters. Statistics: the P adjusted value is shown. ***P <0.001. FDR, false discovery rate.

    Journal: The Journal of Experimental Medicine

    Article Title: Transcriptomics- and 3D imaging–based characterization of the lymphatic vasculature in human skin

    doi: 10.1084/jem.20242353

    Figure Lengend Snippet: Mixed junctional state in capillary LV. (A and B) Whole mounts prepared from the upper 200 µm of the human dermis showing PDPN + LVs and the distribution of the junctional protein VE-cadherin (VE-cad). Representative images from n = 8 donors are shown. (A) Blind-ended lymphatic capillaries with oak leaf–shaped LECs (depicted by an asterisk) or more elongated LECs (depicted by an arrow) were observed in human dermis. (B) Images of LVs with oak leaf–shaped LECs joined by button junctions (depicted by an asterisk) or LVs with more elongated, zipper-like LECs (depicted by an arrow), as well as BVs joined with zipper junctions. Scale bars: 20 µm. (C) Whole mounts of human dermis (upper 200 µm) showing the presence of intracellular CCL21 in afferent LVs stained with anti-VE-cadherin or anti-PDPN antibodies. Representative images from n = 3 donors are shown. Scale bars: 20 µm. (D) GO term analysis of genes enriched in the cap2 LEC subset compared with all other LEC subsets. Selected terms for enriched GO biological and cellular processes are shown along with the −log 10 of the adjusted P value (list of marker genes for the enrichment analysis in ). The vertical line represents the adjusted P value set at an FDR of 0.05. (E) Volcano plot of DEGs between cap1 and cap2 LEC subsets. The horizontal line shows the log 2 fold change (FC) threshold set at 0.75. Vertical lines show the significance threshold for adjusted P values set at an FDR of 0.05. (F) Individual UMAP plots showing the expression of specific cap2 LEC genes, i.e., WWTR1 , ITGA9 , PTK2 , YAP1 , ITGAV , FBN1 . (G and H) Whole mounts prepared from the upper 200 µm of the human dermis showing PDPN + LVs expressing (G) the focal adhesion kinase (FAK), and (H) FAK and the chemokine CCL21. Representative images from n = 3 donors are shown (G and H). Scale bars: 20 µm. For the FAK images, a thin stack at the level of the LV was made to visualize FAK expression specifically in LECs. (I) Human dermal LECs were subjected to mechanical stretch (10% strain every 30 s for 18 h) with a bioreactor. Representative immunofluorescence images of control (static) human dermal LECs and human dermal LECs subjected to stretching are shown. VE-cadherin was used to visualize the cell boundary and subsequent elongation. Scale bar: 100 µm. (J) Aspect ratio of control LECs or stretched LECs was quantified and is represented as a box plot. Statistics were computed with the nonparametric Mann–Whitney test. Pooled data were derived from n = 3 independent replicates with 695 cells analyzed in total. ***P < 0.001. (K) RNA of control or stretched human dermal LECs was extracted, and RT-qPCR was performed. The fold change expression levels of CCL21 and LYVE1 between stretched and control samples are depicted. A fold change below one shows reduced gene expression under stretched conditions. Two independent experiments from n = 3 human dermal LEC donors, with four pooled technical replicates for each. Statistics were computed with paired Student’s t test. **P <0.01. (L) Violin plots showing differential expression of CCL21 and LYVE1 in the cap1 and cap2 clusters. Statistics: the P adjusted value is shown. ***P <0.001. FDR, false discovery rate.

    Article Snippet: Juvenile single donor male human dermal LECs were purchased from PromoCell (C-12216, lot numbers: 431Z006.2, 439Z007.2, and 433Z032.3).

    Techniques: Staining, Marker, Expressing, Immunofluorescence, Control, MANN-WHITNEY, Derivative Assay, Quantitative RT-PCR, Gene Expression, Quantitative Proteomics

    Valve population is composed of two subclusters with different gene expression. (A) Subclustering analysis of the valve cluster revealed two valve subclusters, corresponding to the LECs on the upstream sides of the valve leaflets, and LECs on the downstream sides of the valve leaflets. (B) Volcano plot of DEGs between the upstream valve LEC and downstream valve LEC clusters. The horizontal line shows the log 2 fold change (FC) threshold set at 0.75. Vertical lines show the significance threshold for adjusted P values set at an FDR of 0.05. (C) Individual UMAP plots showing the expression of DEGs in upstream valve LECs ( GJA1 , ITGA9 , NEO1 , CD24 ) and in downstream valve LECs ( GJA4 , CLDN11 , FOXC2 , ANGPT2 ). (D and E) Confocal analysis of valves present in the upper 200 µm of human dermis confirmed (D) the differential expression of FOXC2 and CD24 by LECs on different sides of the valve leaflet, and (E) the colocalization of CD24 and NEO1 by LECs on the same valve leaflet side. Representative images from n = 2–3 independent experiments (donors) are shown in D and E. Scale bars: 20 µm. (F) Schematic illustration of the structure of the valves and the positioning of the LECs within the valves, based on . (G) Schematic illustration of bulk RNA-seq of human dermal LECs subjected to laminar shear stress (4 dyn/cm 2 ), oscillatory-like shear stress (laminar shear stress at 4 dyn/cm 2 that reverses direction by 180° every 4 s), or static conditions for 48 h. The top 50 DEGs in the laminar and oscillatory conditions are shown in and . (G) Pearson correlation plot of the bulk RNA-seq described in E. (H) PCA plot of the samples described in G analyzed at three different conditions (static, oscillatory, and laminar). (I) Similarity of LEC clusters upstream and downstream of valves with the bulk RNA-seq of human dermal LECs subjected to static conditions; laminar or oscillatory flow was determined by the correlation of the top 100 DEGs of valve LEC clusters with the bulk RNA-seq dataset. FDR, false discovery rate.

    Journal: The Journal of Experimental Medicine

    Article Title: Transcriptomics- and 3D imaging–based characterization of the lymphatic vasculature in human skin

    doi: 10.1084/jem.20242353

    Figure Lengend Snippet: Valve population is composed of two subclusters with different gene expression. (A) Subclustering analysis of the valve cluster revealed two valve subclusters, corresponding to the LECs on the upstream sides of the valve leaflets, and LECs on the downstream sides of the valve leaflets. (B) Volcano plot of DEGs between the upstream valve LEC and downstream valve LEC clusters. The horizontal line shows the log 2 fold change (FC) threshold set at 0.75. Vertical lines show the significance threshold for adjusted P values set at an FDR of 0.05. (C) Individual UMAP plots showing the expression of DEGs in upstream valve LECs ( GJA1 , ITGA9 , NEO1 , CD24 ) and in downstream valve LECs ( GJA4 , CLDN11 , FOXC2 , ANGPT2 ). (D and E) Confocal analysis of valves present in the upper 200 µm of human dermis confirmed (D) the differential expression of FOXC2 and CD24 by LECs on different sides of the valve leaflet, and (E) the colocalization of CD24 and NEO1 by LECs on the same valve leaflet side. Representative images from n = 2–3 independent experiments (donors) are shown in D and E. Scale bars: 20 µm. (F) Schematic illustration of the structure of the valves and the positioning of the LECs within the valves, based on . (G) Schematic illustration of bulk RNA-seq of human dermal LECs subjected to laminar shear stress (4 dyn/cm 2 ), oscillatory-like shear stress (laminar shear stress at 4 dyn/cm 2 that reverses direction by 180° every 4 s), or static conditions for 48 h. The top 50 DEGs in the laminar and oscillatory conditions are shown in and . (G) Pearson correlation plot of the bulk RNA-seq described in E. (H) PCA plot of the samples described in G analyzed at three different conditions (static, oscillatory, and laminar). (I) Similarity of LEC clusters upstream and downstream of valves with the bulk RNA-seq of human dermal LECs subjected to static conditions; laminar or oscillatory flow was determined by the correlation of the top 100 DEGs of valve LEC clusters with the bulk RNA-seq dataset. FDR, false discovery rate.

    Article Snippet: Juvenile single donor male human dermal LECs were purchased from PromoCell (C-12216, lot numbers: 431Z006.2, 439Z007.2, and 433Z032.3).

    Techniques: Gene Expression, Expressing, Quantitative Proteomics, RNA Sequencing, Shear

    Bulk RNA-seq of human dermal LECs subjected to laminar or oscillatory shear stress. (A) Selected pathways from Enrichr analysis (GO terms) of DEGs upregulated in the LECs on the upstream sides of valve leaflets or upregulated in LECs on the downstream sides of valve leaflets (list of DEGs used for the enrichment analysis in ). The vertical line represents the adjusted P value set at an FDR of 0.05. (B) Flow cytometry analysis of CD31 and PDPN expression of the three human dermal LEC donors used for bulk RNA-seq. Cells were gated on single cells, followed by viable cells, and the expression histograms shown in this panel. (C) Volcano plots of significant DEGs when comparing laminar or oscillatory shear stress to static control. (D) Heatmap of expression levels of selected genes in the bulk RNA-seq study. FDR, false discovery rate.

    Journal: The Journal of Experimental Medicine

    Article Title: Transcriptomics- and 3D imaging–based characterization of the lymphatic vasculature in human skin

    doi: 10.1084/jem.20242353

    Figure Lengend Snippet: Bulk RNA-seq of human dermal LECs subjected to laminar or oscillatory shear stress. (A) Selected pathways from Enrichr analysis (GO terms) of DEGs upregulated in the LECs on the upstream sides of valve leaflets or upregulated in LECs on the downstream sides of valve leaflets (list of DEGs used for the enrichment analysis in ). The vertical line represents the adjusted P value set at an FDR of 0.05. (B) Flow cytometry analysis of CD31 and PDPN expression of the three human dermal LEC donors used for bulk RNA-seq. Cells were gated on single cells, followed by viable cells, and the expression histograms shown in this panel. (C) Volcano plots of significant DEGs when comparing laminar or oscillatory shear stress to static control. (D) Heatmap of expression levels of selected genes in the bulk RNA-seq study. FDR, false discovery rate.

    Article Snippet: Juvenile single donor male human dermal LECs were purchased from PromoCell (C-12216, lot numbers: 431Z006.2, 439Z007.2, and 433Z032.3).

    Techniques: RNA Sequencing, Shear, Flow Cytometry, Expressing, Control

    CD24 expression in murine and human dermal LECs in vitro and in vivo . (A) RNA expression in FPKM in three donors of human dermal LECs subjected to laminar (lam) shear stress, oscillatory (osc) shear stress, or static conditions (data from the bulk RNA-seq). (B) CD24 is not expressed at the protein level in in vitro –cultured human dermal LECs as assessed by flow cytometry. Representative flow cytometry plot of donor 431Z006.2. Donors 433Z032.3 and 439Z007.2 neither expressed CD24. (C) CD24 expression in mouse dermal imLECs. Representative flow cytometry plot of three experiments. (D and E) Whole mounts of Prox1- eGFP mouse ear showing expression of (D) CD24 in lymphatic valves visualized with Prox1 (high in valves) and (E) in combination with the cell adhesion molecule CD31. Representative images from five independent experiments. Scale bars: (D) 100 µm, (E) 25 µm. (F and G) Quantification of ITGA9 + valves was performed in 6-image Tilescans acquired in an ear skin area containing predominantly collectors (coll: CD31 + aSMA + ) or pre-collectors (precoll: CD31 + aSMA − ). (F) Representative image of a Tilescan (left) and of ITAGA9 + valves in CD31 + aSMA − pre-collecting (middle) and CD31 + aSMA + collecting vessels (right). Scale bars from left to right: 150, 100, 50 µm. (G) Quantifications of valves in the pre-collector or collector area of ear skin whole mounts from adult WT ( Cd24 +/+ ) and Cd24 −/− mice ( n = 8 WT and n = 7 Cd24 −/− ). (H and I) Lymphatic drainage assay: adult WT and Cd24 −/− mice were injected with a near-infrared dye conjugate intradermally in the ear skin. Clearance of the tracer was monitored over 24 h by IVIS imaging. (H and I) (H) Average dye clearance plots and (I) calculated half-lives in WT and Cd24 − /− mice (data from one experiment with four to five mice per group are shown). ns, not significant; FPKM, fragments per kilobase of transcript per million mapped reads.

    Journal: The Journal of Experimental Medicine

    Article Title: Transcriptomics- and 3D imaging–based characterization of the lymphatic vasculature in human skin

    doi: 10.1084/jem.20242353

    Figure Lengend Snippet: CD24 expression in murine and human dermal LECs in vitro and in vivo . (A) RNA expression in FPKM in three donors of human dermal LECs subjected to laminar (lam) shear stress, oscillatory (osc) shear stress, or static conditions (data from the bulk RNA-seq). (B) CD24 is not expressed at the protein level in in vitro –cultured human dermal LECs as assessed by flow cytometry. Representative flow cytometry plot of donor 431Z006.2. Donors 433Z032.3 and 439Z007.2 neither expressed CD24. (C) CD24 expression in mouse dermal imLECs. Representative flow cytometry plot of three experiments. (D and E) Whole mounts of Prox1- eGFP mouse ear showing expression of (D) CD24 in lymphatic valves visualized with Prox1 (high in valves) and (E) in combination with the cell adhesion molecule CD31. Representative images from five independent experiments. Scale bars: (D) 100 µm, (E) 25 µm. (F and G) Quantification of ITGA9 + valves was performed in 6-image Tilescans acquired in an ear skin area containing predominantly collectors (coll: CD31 + aSMA + ) or pre-collectors (precoll: CD31 + aSMA − ). (F) Representative image of a Tilescan (left) and of ITAGA9 + valves in CD31 + aSMA − pre-collecting (middle) and CD31 + aSMA + collecting vessels (right). Scale bars from left to right: 150, 100, 50 µm. (G) Quantifications of valves in the pre-collector or collector area of ear skin whole mounts from adult WT ( Cd24 +/+ ) and Cd24 −/− mice ( n = 8 WT and n = 7 Cd24 −/− ). (H and I) Lymphatic drainage assay: adult WT and Cd24 −/− mice were injected with a near-infrared dye conjugate intradermally in the ear skin. Clearance of the tracer was monitored over 24 h by IVIS imaging. (H and I) (H) Average dye clearance plots and (I) calculated half-lives in WT and Cd24 − /− mice (data from one experiment with four to five mice per group are shown). ns, not significant; FPKM, fragments per kilobase of transcript per million mapped reads.

    Article Snippet: Juvenile single donor male human dermal LECs were purchased from PromoCell (C-12216, lot numbers: 431Z006.2, 439Z007.2, and 433Z032.3).

    Techniques: Expressing, In Vitro, In Vivo, RNA Expression, Shear, RNA Sequencing, Cell Culture, Flow Cytometry, Injection, Imaging

    Lymphatic endothelial cells (LEC) were supplemented with various concentrations of glutamine (Gln; top pathway) or had their glutamine transport inhibited with V-9302 (bottom pathway). After initial treatments, cells were then incubated in normoxic (∼21% O 2 ) or hypoxic (>3% O 2 ) conditions. Image created in BioRender.

    Journal: bioRxiv

    Article Title: Glutamine Availability Impacts Lymphatic Endothelial Cell Glycolysis and Lymphangiogenesis in Hypoxic Environments

    doi: 10.64898/2025.12.18.695240

    Figure Lengend Snippet: Lymphatic endothelial cells (LEC) were supplemented with various concentrations of glutamine (Gln; top pathway) or had their glutamine transport inhibited with V-9302 (bottom pathway). After initial treatments, cells were then incubated in normoxic (∼21% O 2 ) or hypoxic (>3% O 2 ) conditions. Image created in BioRender.

    Article Snippet: Juvenile Human Dermal Lymphatic Endothelial Cells were acquired from Promocell and expanded in PromoCell Endothelial Growth Medium MV2 (MV2) with associated SupplementMix.

    Techniques: Incubation